Molecular targeted agents—where we are and where we are going
A total of 23 new cancer medicines or indication expansions were approved by the U. S. Food and Drug Administration in 2012. Among these, 12 are new molecular entities (NMEs)—new chemical or biological drugs approved for the first time for oncologic use—and 10 of these NMEs are molecular targeted ag...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Sun Yat-sen University Cancer Center
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845551/ |